These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka. Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092 [No Abstract] [Full Text] [Related]
24. [Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers]. Rautlin de la Roy Y DE; Beauchant G; Brisou J; Dussouil P; Charpentier Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1054-9. PubMed ID: 4317484 [No Abstract] [Full Text] [Related]
25. Primary drug resistance to PAS, INH and streptomycin in tubercle bacilli isolated from cases of open pulmonary tuberculosis. Rajvanshi VS; Tiagi GK Indian J Med Sci; 1968 Nov; 22(11):786-91. PubMed ID: 4974030 [No Abstract] [Full Text] [Related]
26. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study. Doster B; Caras GJ; Snider DE Am Rev Respir Dis; 1976 Apr; 113(4):419-25. PubMed ID: 817629 [TBL] [Abstract][Full Text] [Related]
27. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples]. Romano S; Grella G Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869 [No Abstract] [Full Text] [Related]
28. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy]. Freerksen E Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222 [No Abstract] [Full Text] [Related]
30. [The importance of initial chemotherapy in tuberculosis control programs]. Anastasatu C Ann Ist Super Sanita; 1966; 2(2):458-70. PubMed ID: 4309078 [No Abstract] [Full Text] [Related]
31. Virulence of multidrugresistant Mycobacterium tuberculosis. Zykov MP; Roulet H; Gaya N; Poti SJ Exp Pathol (Jena); 1973; 8(2):73-97. PubMed ID: 4204722 [No Abstract] [Full Text] [Related]
33. [Comments on the current state of experimental chemotherapy of tuberculosis]. Urbancík R; Markovic J Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152 [No Abstract] [Full Text] [Related]
34. Primary resistance to the major drugs in tuberculous patients, in 1961-1966. Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D Pol Med J; 1969; 8(5):1131-5. PubMed ID: 4986628 [No Abstract] [Full Text] [Related]
36. Cycloserine in the treatment of pulmonary tuberculosis. Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969 [No Abstract] [Full Text] [Related]
37. Chemotherapy of tuberculosis. I. Typical Mycobacterium tuberculosis--primary drugs. J Kans Med Soc; 1968 Sep; 69(9):445-8. PubMed ID: 4971623 [No Abstract] [Full Text] [Related]
38. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis]. Belogurova VP Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222 [No Abstract] [Full Text] [Related]
39. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis]. Tipp ZI Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468 [No Abstract] [Full Text] [Related]